Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
|Videos|June 28, 2016
What is the Difference Between Staph and MRSA?
Author(s)Contagion Editorial Staff
Jeff Boyd, PhD, assistant professor of Biochemistry and Microbiology at Rutgers School of Environmental and Biological Sciences, explains the difference between Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus.
Advertisement
Jeff Boyd, PhD, assistant professor of Biochemistry and Microbiology at Rutgers School of Environmental and Biological Sciences, explains the difference between Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus.
Interview Transcript (slightly modified for readability)
“So methicillin[-resistant] Staph aureus is different than more commonly found Staphylococcus aureus in that it is resistant to an antibiotic called methicillin. Typically, it is resistant to all beta lactam antibiotics.
If you go into a clinic, a physician, if they treated you with a beta lactam antibiotic, methicillin-resistant Staphylococcus aureus would be able to resist the treatment, it would be able to survive in the presence of that antibiotic.”
Advertisement
Related to this article
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
In the second episode of the series with Perry N. Halkitis, PhD, MS, MPH, he brings his personal experience to this topic and questions whether there should be a shift in who manages the primary care needs of these patients.
Gavin Harris, MD, provides some context around what is happening in the Democratic Republic of Congo regarding the outbreak including the country’s inherent challenges as well as discussing the latest in testing, vaccines, and treatments of this rare strain of Ebola.
Advertisement
Advertisement
Trending on Contagion Live
1
A Pennsylvania Teen Dies From Rare Measles Neurological Complication
2
Ceftriaxone Safety: Separating Signal From Risk
3
Revisiting Whether Cefepime Raises Mortality Risk
4
New York City Orders Tower Cleanings, Announces Prevention Measures in Addressing Legionnaires' Disease Cluster
5